EP 3242671 A1 20171115 - EX VIVO METHODS FOR MINIMIZING RISKS AND MAXIMIZING BENEFITS OF ALLOGENEIC BLOOD AND MARROW TRANSPLANTATION
Title (en)
EX VIVO METHODS FOR MINIMIZING RISKS AND MAXIMIZING BENEFITS OF ALLOGENEIC BLOOD AND MARROW TRANSPLANTATION
Title (de)
EX VIVO-VERFAHREN ZUR MINIMIERUNG DER RISIKEN UND MAXIMIERUNG DER VORTEILE VON ALLOGENER BLUT- UND KNOCHENMARKTRANSPLANTATION
Title (fr)
PROCÉDÉS EX VIVO POUR MINIMISER LES RISQUES ET MAXIMISER LES EFFETS BÉNÉFIQUES D'UNE TRANSFUSION DE SANG ALLOGÉNIQUE ET GREFFE DE MOELLE
Publication
Application
Priority
- US 201562101181 P 20150108
- US 2016012573 W 20160108
Abstract (en)
[origin: WO2016112245A1] The described invention provides an ex vivo model of persistent T lymphocyte stimulation events encountered by circulating T lymphocytes at lymph node and tissue levels in vivo; a method for optimizing donor selection for allogeneic blood and marrow transplantation (BMT) therapy; and a method for minimizing risks and maximizing benefits of performing allogeneic blood and marrow transplantation (BMT) therapy in a recipient subject, wherein the recipient subject has a hematologic malignancy.
IPC 8 full level
A61K 35/17 (2015.01)
CPC (source: EP)
A61K 39/4611 (2023.05); A61K 39/4615 (2023.05); A61K 39/4621 (2023.05); A61K 39/4622 (2023.05); A61K 39/46434 (2023.05); G01N 33/505 (2013.01); A61K 2239/26 (2023.05); G01N 2800/245 (2013.01)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2016112245 A1 20160714; CA 2972846 A1 20160714; EP 3242671 A1 20171115; EP 3242671 A4 20180808
DOCDB simple family (application)
US 2016012573 W 20160108; CA 2972846 A 20160108; EP 16735447 A 20160108